AZTRNYSEPharmaceutical PreparationsFiscal year ends December 31
Azitra, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.07+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $1.38M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
35.7%
22M of 61M shares
Institutional holders
14
8 new, 1 sold out
Net institutional buying
21M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Daniel Mack | 6,480,584 | 9.99% | 13G (passive) | Jun 30, 2026 |
| Dauntless Investment Group, LLC | 5,804,636 | 9.60% | 13G (passive) | Jun 24, 2026 |
| Nantahala Capital Partners Limited Partnership | 5,448,213 | 8.40% | 13G (passive) | Jun 30, 2026 |
| Salva Francisco D. | 5,421,039 | 9.99% | 13D (active) | Jun 16, 2026 |
| Alumni Capital GP LLC | 2,605,586 | 9.99% | 13G (passive) | Apr 24, 2025 |
| Stonepine Capital, L.P. | 1,744,339 | 9.90% | 13G (passive) | Jun 16, 2026 |
| Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B | 1,662,525 | 9.99% | 13G (passive) | Mar 31, 2025 |
| Ashkan Mapar | 1,132,622 | 9.99% | 13G (passive) amendment | Nov 25, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of AZTR | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Dauntless Investment Group, LLC | 11,292,186 | 18.63% | $1.89M | +11,291,186 | 1.49% |
| Stonepine Capital Management, LLC | 5,285,476 | 8.72% | $886.90K | New | 0.50% |
| Nantahala Capital Management, LLC | 4,427,226 | 7.31% | $742.89K | New | 0.01% |
| Jane Street Group, LLC | 248,433 | 0.41% | $41.69K | New | 0.00% |
| Geode Capital Management, LLC | 95,409 | 0.16% | $16.01K | −374,469 | 0.00% |
| Citadel Advisors LLC | 86,242 | 0.14% | $14.47K | New | 0.00% |
| Virtu Financial LLC | 64,940 | 0.11% | $11 | New | 0.00% |
| UBS Group AG | 50,481 | 0.08% | $8.48K | +20,276 | 0.00% |
| StoneX Group Inc. | 28,651 | 0.05% | $5.03K | +6,187 | 0.00% |
| Tower Research Capital LLC (TRC) | 19,500 | 0.03% | $3.27K | +4,415 | 0.00% |
| Corient Private Wealth LLC | 14,451 | 0.02% | $2.43K | New | 0.00% |
| Susquehanna International Group, Llp | 12,237 | 0.02% | $2.05K | New | 0.00% |
| Citigroup Inc | 6,149 | 0.01% | $1.03K | +4,444 | 0.00% |
| Barclays PLC | 1 | 0.00% | $0 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 14 | 22M | 35.7% | 8 / 5 | 1 / 1 | 21M | 0M |
| Q1 2026 | 7 | 1M | 0.9% | 4 / 3 | 0 / 6 | 0M | 0M |
| Q4 2025 | 9 | 0M | 0.4% | 5 / 3 | 1 / 1 | 0M | 0M |
| Q3 2025 | 5 | 0M | 0.1% | 5 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of AZTR | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 359,022 | 0.59% | $82.58K | 0.00% | May 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -15 | -0.00% | -$3 | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Francisco D. Salva | President and CEO, Director | 4,086,291 | 6.74% | Jun 18, 2026 |
| Travis Whitfill | Chief Operating Officer, Director | 334,500 | 0.55% | Apr 22, 2026 |
| Norm Staskey | Chief Financial Officer | 51,100 | 0.08% | Apr 22, 2026 |
| John R. Schroer | Director | – | – | Dec 22, 2025 |
| Barbara Ryan | Director | – | – | Dec 22, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Francisco D. Salva President and CEO, Director | Jun 16, 2026 | Conversion | +4,064,050 | – | – | 4,086,291 |
| Norm Staskey Chief Financial Officer | Mar 29, 2024 | Buy | +47,600 | $0.21 | $10.00K | 51,100 |
| Francisco D. Salva President and CEO, Director | Feb 13, 2024 | Buy | +333,300 | $0.30 | $99.99K | 338,300 |
| Norm Staskey Chief Financial Officer | Feb 13, 2024 | Buy | +3,300 | $0.30 | $990 | 3,500 |
| Travis Whitfill Chief Operating Officer, Director | Feb 13, 2024 | Buy | +15,000 | $0.30 | $4.50K | 334,500 |
| World Investments B.V. Bayer 10% owner | Jun 21, 2023 | Conversion | +1,307,401 | – | – | 1,307,401 |
| Andrew McClary Director | Jun 21, 2023 | Conversion | +249,474 | – | – | 249,474 |
| Andrew McClary Director | Jun 21, 2023 | Conversion | +42,437 | – | – | 291,911 |
| Andrew McClary Director | Jun 21, 2023 | Conversion | +42,347 | – | – | 42,347 |
| Andrew McClary Director | Jun 21, 2023 | Conversion | +16,975 | – | – | 16,975 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Conversion | +436,173 | – | – | 436,173 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Conversion | +25,280 | – | – | 137,000 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Conversion | +111,720 | – | – | 111,720 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Conversion | +188,810 | – | – | 1,023,442 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Conversion | +834,632 | – | – | 834,632 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Conversion | +57,747 | – | – | 313,250 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Conversion | +255,503 | – | – | 255,503 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Conversion | +799,467 | – | – | 799,467 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Conversion | +467,613 | – | – | 467,613 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Conversion | +144,705 | – | – | 426,944 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Buy | +73,708 | $5.00 | $368.54K | 282,239 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Buy | +208,531 | – | – | 208,531 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Sale | −82,223 | – | – | 0 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Conversion | +896,035 | – | – | 2,643,705 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Buy | +456,412 | $5.00 | $2.28M | 1,747,670 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Buy | +1,291,258 | – | – | 1,291,258 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Sale | −509,141 | – | – | 0 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Conversion | +137,186 | – | – | 404,767 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Buy | +69,880 | $5.00 | $349.40K | 267,581 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Buy | +197,701 | – | – | 197,701 |
| BIOS Fund III NT, LP 10% owner | Jun 21, 2023 | Sale | −77,953 | – | – | 0 |
| Francisco D. Salva President and CEO, Director | Jun 21, 2023 | Award | +5,000 | $5.00 | $25.00K | 5,000 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Conversion | +436,173 | – | – | 436,173 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Conversion | +25,280 | – | – | 137,000 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Conversion | +188,810 | – | – | 1,023,442 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Conversion | +834,632 | – | – | 834,632 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Conversion | +57,747 | – | – | 313,250 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Conversion | +255,503 | – | – | 255,503 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Conversion | +799,467 | – | – | 799,467 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Conversion | +467,613 | – | – | 467,613 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Conversion | +144,705 | – | – | 426,944 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Buy | +73,708 | $5.00 | $368.54K | 282,239 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Buy | +208,531 | – | – | 208,531 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Sale | −82,223 | – | – | 0 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Conversion | +896,035 | – | – | 2,643,705 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Buy | +456,412 | $5.00 | $2.28M | 1,747,670 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Buy | +1,291,258 | – | – | 1,291,258 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Sale | −509,141 | – | – | 0 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Conversion | +137,186 | – | – | 404,767 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Buy | +69,880 | $5.00 | $349.40K | 267,581 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Buy | +197,701 | – | – | 197,701 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Sale | −77,953 | – | – | 0 |
| Cavu Advisors, LLC 10% owner | Jun 21, 2023 | Conversion | +111,720 | – | – | 111,720 |
| Travis Whitfill Chief Operating Officer, Director | Jun 21, 2023 | Award | +250 | $5.00 | $1.25K | 250 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Kdt Ventures Fund I, Lp Former Director | Sep 16, 2024 | 9,730 | $5.65K | Sep 13, 2024 | Conversion of convertible note |